Clinical Trial

Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery

Study acronym: AEROBIKA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This randomized clinical study aims to assess the use of an oscillating positive expiratory pressure device (AEROBIKA) in patients with thoracic neoplasms who undergo chest surgery. The main questions it aims to answer are: If the use of the AEROBIKA device reduces the incidence of atelectasis in oncological patients undergoing lung resection. If the use of the AEROBIKA device reduces hospital readmission and days of hospital stay. Participants who accept to participate will be sorted to receive a conventional rehab therapy (group A), otherwise a conventional rehab therapy plus AEROBIKA device (group B). Researchers will compare patients from group A versus group B to see if patients develop atelectasis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-24; most recent amendment 2026-04-06.
Status change: Recruiting → Active, Not Recruiting 2023-04-19
Trial Details
NCT Number NCT05267496
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions Lung Cancer, Mediastinal Tumor, Pleural Tumor
Enrollment 72 participants
Start Date 2019-08-13
Primary Completion 2023-02-28 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-08